FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1
FTO-medicated m6A modification of DACT1 was dependent on IGF2BP1 in DN progression.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-05-01
|
| Series: | Open Life Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/biol-2022-1049 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|